This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results

Stocks in this article: AEGR

For additional disclosure regarding these and other risks we face, see the disclosure contained in the "Risk Factors" section of Aegerion's Annual Report on Form 10-K filed on March 18, 2013, and our other public filings with the Securities and Exchange Commission, available on the SEC's website at . We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

Aegerion Pharmaceuticals, Inc. 
Condensed Consolidated Statements of Operations 
  Three Months Ended March 31,
(In 000s) 2013 2012
Net product sales  $ 1,231  $ -- 
Cost of sales  183  -- 
Operating expenses:    
Selling, general and administrative  13,220 5,111
Research and development  5,775  4,635
Restructuring costs  1  831
Total operating expenses  18,996  10,577
Loss from operations  (17,948) (10,577)
Interest expense, net  (149) (286)
Other expense, net  (45) (802)
Net loss  $ (18,142)  $ (11,665)
Net loss per common share - basic and diluted  $ (0.64)  $ (0.55)
Weighted-average shares outstanding - basic and diluted  28,337  21,246
Aegerion Pharmaceuticals, Inc. 
Condensed Consolidated Balance Sheets 
(In 000s) March 31, 2013 December 31, 2012
Cash, cash equivalents and marketable securities  $ 140,689  $ 82,177
Accounts receivable, net  763  -- 
Inventory  841  -- 
Prepaid expenses and other current assets  2,233  1,571
Restricted cash  105  105
Property and equipment, net  1,236  1,143
Other assets  93  93
Total assets  $ 145,960  $ 85,089
Accounts payable and accrued expenses  $ 8,732  $ 13,904
Current portion of long-term debt  3,578  3,022
Long-term debt  6,695  7,589
Other noncurrent liabilities  190  173
Total liabilities  19,195  24,688
Total stockholders' equity  126,765  60,401
Total liabilities and stockholders' equity  $ 145,960  $ 85,089
CONTACT: Aegerion Pharmaceuticals, Inc.
         Amanda Murphy
         Manager, Investor Relations
         (857) 242-5024

Aegerion Pharmaceuticals, Inc. Logo

4 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,090.23 +60.02 0.33%
S&P 500 2,092.37 +10.49 0.50%
NASDAQ 4,813.8910 +40.4190 0.85%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs